SARS-CoV-2 spike protein plasmid DNA vaccine CORVax

{
  "id": "MLC-T-ONC-016648",
  "term": "SARS-CoV-2 spike protein plasmid DNA vaccine CORVax",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine consisting of DNA plasmids encoding the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity against SARS-CoV-2. Upon administration of the SARS-CoV-2 S protein plasmid DNA vaccine CORVax and following electroporation (EP), the DNA plasmids enter the cells and the cells produce the SARS-CoV-2 S protein. This may activate both humoral and cellular immune responses which may result in protection against SARS-CoV-2 infection. S protein, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus.",
  "synonyms": [
    "SARS-CoV-2 S-protein DNA vaccine CORVax",
    "SARS-CoV-2 S-protein plasmid DNA vaccine CORVax"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/sars-cov-2-spike-protein-plasmid-dna-vaccine-corvax/"
}